| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.098 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.058 | 0.3 |